1. Home
  2. Analysis
  3. Cefobid
  4. Liver-function-tests-nos-abnormal

Cefobid and Liver function tests nos abnormal - a phase IV clinical study of FDA data

Summary:

Liver function tests nos abnormal is reported as a side effect among people who take Cefobid (cefoperazone sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Famotidine,.

The phase IV clinical study analyzes which people have Liver function tests nos abnormal when taking Cefobid. It is created by eHealthMe based on reports of 1,316 people who have side effects when taking Cefobid from the FDA, and is updated regularly.

What is Cefobid?

Cefobid has active ingredients of cefoperazone sodium. eHealthMe is studying from 1,317 Cefobid users. Check the latest studies of Cefobid.

What is Liver function tests nos abnormal?

Liver function tests nos abnormal is found to be associated with 800 drugs and 192 conditions by eHealthMe. Check the latest studies of Liver function tests nos abnormal.

On Jun, 12, 2026

1,316 people reported to have side effects when taking Cefobid.
Among them, 67 people (5.09%) have Liver function tests nos abnormal.

Could Cefobid cause Liver function tests nos abnormal?

Among these 67 people:

How long have people been on Cefobid when they have Liver function tests nos abnormal? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Liver function tests nos abnormal when taking Cefobid? *

  • female: 45.9 %
  • male: 54.1 %

What is the age of people who have Liver function tests nos abnormal when taking Cefobid? *

  • 0-1: 1.92 %
  • 2-9: 1.92 %
  • 10-19: 0.0 %
  • 20-29: 7.69 %
  • 30-39: 5.77 %
  • 40-49: 1.92 %
  • 50-59: 15.38 %
  • 60+: 65.38 %

What are other drugs people take besides Cefobid? *

  1. Famotidine: 8 people, 11.94%
  2. Prednisolone: 7 people, 10.45%
  3. Cyclosporine: 5 people, 7.46%
  4. Amlodipine: 5 people, 7.46%
  5. Ceftriaxone: 4 people, 5.97%
  6. Ranitidine Hydrochloride: 3 people, 4.48%
  7. Cimetidine: 3 people, 4.48%
  8. Fluconazole: 3 people, 4.48%
  9. Cloxacillin Sodium: 2 people, 2.99%
  10. Diclofenac Sodium: 2 people, 2.99%

What are other side effects people have besides Liver function tests nos abnormal? *

  1. Fever: 12 people, 17.91%
  2. Blood Bilirubin Increased: 11 people, 16.42%
  3. Drug Hypersensitivity: 7 people, 10.45%
  4. Thrombocytopenia (decrease of platelets in blood): 7 people, 10.45%
  5. Blood Creatinine Increased: 6 people, 8.96%
  6. C-Reactive Protein Increased: 6 people, 8.96%
  7. White Blood Cell Count Increased: 5 people, 7.46%
  8. Blood Urea Increased: 5 people, 7.46%
  9. White Blood Cell Count Decreased: 4 people, 5.97%
  10. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 5.97%

* Approximation only. Some reports may have incomplete information.

Do you take Cefobid and have Liver function tests nos abnormal?

- Check whether Liver function tests nos abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefobid:

Liver function tests nos abnormal treatments and more:

How severe was Liver function tests nos abnormal and when was it recovered:

Expand to all the drugs that have ingredients of cefoperazone sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function tests nos abnormal:

Browse all the conditions that are associated with Liver function tests nos abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on cefoperazone sodium (the active ingredients of Cefobid) and Cefobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.